In a nutshell This study examined a treatment for advanced Hodgkin lymphoma, haploidentical stem cell transplantation with post-infusion cyclophosphamide (haplo-HSCT). The authors concluded that the use of haplo-HSCT is a valid treatment option for patients with advanced Hodgkin lymphoma (HL). Some background Hodgkin lymphoma is...
Read More
In a nutshell This study compared the survival outcomes of two different age groups of relapsed and refractory Hodgkin lymphoma patients. The authors concluded that co-morbidities, not age, reduced survival rates after stem-cell surgery. Some background Hodgkin lymphoma (HL) is a type of cancer of the lymph system. It is generally highly...
Read More
In a nutshell This study evaluated the effectiveness of brentuximab-vedotin therapy in relapsed- and refractory Hodgkin lymphoma patients. The authors concluded that the treatment was safe and effective. Some background Some Hodgkin lymphoma patients are either unresponsive to treatment (refractory disease), or relapse soon...
Read More
